Holen Sie sich die Stockscreener-App
71.46
1.60%
-1.16
Schlusskurs vom Vortag:
$72.62
Offen:
$71.96
24-Stunden-Volumen:
2.05M
Relative Volume:
1.29
Marktkapitalisierung:
$8.70B
Einnahmen:
$12.50B
Nettoeinkommen (Verlust:
$314.00M
KGV:
29.29
EPS:
2.44
Netto-Cashflow:
$421.00M
1W Leistung:
+3.42%
1M Leistung:
-1.83%
6M Leistung:
-4.68%
1J Leistung:
+0.59%
1-Tages-Spanne:
$71.23
$71.96
1-Wochen-Bereich:
$69.05
$74.74
52-Wochen-Spanne:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Vergleichen Sie HSIC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
71.46 | 9.08B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
711.82 | 88.71B | 359.05B | 3.30B | 5.23B | 25.83 |
|
COR
Cencora Inc
|
290.36 | 56.30B | 310.23B | 1.69B | 3.58B | 8.62 |
|
CAH
Cardinal Health Inc
|
157.14 | 37.78B | 222.29B | 1.56B | 2.44B | 6.41 |
|
AHG
Akso Health Group Adr
|
2.00 | 701.93M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Henry Schein Inc. Stock Analysis and ForecastUnmatched market gains - PrintWeekIndia
Henry Schein (HSIC) Downgraded Amid Market Share Concerns - GuruFocus
Henry Schein stock downgraded at Stifel (HSIC:NASDAQ) - Seeking Alpha
Henry Schein (HSIC) Downgraded by Stifel, Price Target Cut to $75 | HSIC Stock News - GuruFocus
Henry Schein stock downgraded by Stifel on market share concerns - Investing.com
What drives Henry Schein Inc. stock pricePhenomenal returns - Autocar Professional
Stifel Adjusts Henry Schein (HSIC) Rating Amid Market Challenges - GuruFocus
Stifel Adjusts Henry Schein (HSIC) Rating Amid Market Challenges | HSIC Stock News - GuruFocus
Acadia Healthcare, Henry Schein, The Pennant Group, Ziff Davis, and Atlassian Shares Are Soaring, What You Need To Know - TradingView
Will CEO Succession Impact Henry Schein's (HSIC) Digital Transformation and Efficiency Goals? - simplywall.st
What analysts say about Henry Schein Inc. stockOutstanding trading profits - jammulinksnews.com
Lobbying Update: $20,000 of HENRY SCHEIN lobbying was just disclosed - Quiver Quantitative
Is Henry Schein Inc. a good long term investmentFree Daily Trading Room Entry - jammulinksnews.com
Henry Schein Announces Q2 2025 Earnings Release and Conference Call - AInvest
Henry Schein to Webcast Second Quarter 2025 Conference Call on Tuesday, August 5, 2025, at 8:00 a.m. ET - Business Wire
Henry Schein's Quarterly Earnings Preview: What You Need to Know - MSN
What caused HSIC's 2024 earnings surprises? - AInvest
Henry Schein, Inc. (NASDAQ:HSIC) Has Fared Decently But Fundamentals Look Uncertain: What Lies Ahead For The Stock? - simplywall.st
Henry Schein announces CEO retirement - MSN
Insiders At Henry Schein Sold US$2.3m In Stock, Alluding To Potential Weakness - 富途牛牛
IntelePeer Joins Henry Schein One Academic Partner Program to Enhance Dental Education with Conversational AI - AInvest
IntelePeer Joins Henry Schein One Academic Partner Program - Yahoo Finance
Stanley M. Bergman to retire as Henry Schein CEO - Dental Tribune US
Henry Schein CEO Stanley Bergman Announces Retirement - The Globe and Mail
Henry Schein's Quarterly Earnings Preview: What You Need To Know - Barchart.com
Henry Schein CEO Stanley Bergman to retire - Newsday
Stanley Bergman To Retire as Henry Schein’s CEO at the End of The Year - Dentistry Today
Longtime Henry Schein CEO to Retire at End of 2025 - Modern Distribution Management
Stan Bergman to retire after 35 years as CEO of Henry Schein - Fierce Biotech
Henry Schein climbs; longtime CEO to retire - TradingView
Stanley M. Bergman To Retire as Henry Schein’s CEO - citybiz
Henry Schein falls after longtime CEO to retire - TradingView
Henry Schein announces CEO retirement (HSIC:NASDAQ) - Seeking Alpha
Henry Schein CEO Stanley Bergman to Retire at Yearend - MarketScreener
Henry Schein's Stanley Bergman to Retire as CEO at End of Year - MarketWatch
Stanley M. Bergman to Retire as Henry Schein’s Chief Executive Officer at the End of 2025 - The Globe and Mail
Henry Schein CEO Retires After 35 Years: How He Transformed $225M Company Into $13B Healthcare Giant - Stock Titan
Why Henry Schein Inc. stock attracts strong analyst attentionBig Profit Small Risk Alerts - beatles.ru
Henry Schein Inc. stock underperforms Monday when compared to competitors - MSN
Henry Schein Trading Volume Surges 119.05% to Rank 412th Amid Stock Price Decline - AInvest
Henry Schein Stock Downgraded: Potential Loss of Major CustomerNews and Statistics - IndexBox
Why Henry Schein (HSIC) Shares Are Falling Today - Yahoo Finance
Henry Schein (HSIC) Price Target Raised Ahead of Q2 Earnings | H - GuruFocus
This Procter & Gamble Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
Baird Downgrades Henry Schein to Neutral From Outperform, Adjusts Price Target to $72 From $82 - MarketScreener
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
13.64%
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):